Publication: The optimal dose of potassium citrate in the treatment of children with distal renal tubular acidosis
Issued Date
2002-11-01
Resource Type
ISSN
01252208
Other identifier(s)
2-s2.0-0036881438
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol.85, No.SUPPL. 4 (2002)
Suggested Citation
Wiwat Tapaneya-Olarn, Sukkasem Khositseth, Chaleomsri Tapaneya-Olarn, Narumon Teerakarnjana, Upsorn Chaichanajarernkul, Wasana Stitchantrakul, Thanom Petchthong The optimal dose of potassium citrate in the treatment of children with distal renal tubular acidosis. Journal of the Medical Association of Thailand. Vol.85, No.SUPPL. 4 (2002). Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/20317
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
The optimal dose of potassium citrate in the treatment of children with distal renal tubular acidosis
Other Contributor(s)
Abstract
Background: Distal renal tubular acidosis (RTA) is a common cause of intractable calcium nephrolithiasis. In adults, the use of potassium citrate (PC) in distal RTA effectively decreases metabolic acidosis and the risk of calcium oxalate stone but it cannot decrease the risk of calcium phosphate stone. However, there is no report for the optimal dose of PC and the risk of calcium stone in distal RTA in children. Objective: To evaluate the optimal dose of PC that minimizes the risk of calcium nephrolithiasis in children with distal RTA. Method: Prospective study Patients: Children who have distal RTA and were followed-up for 4 months. Patients were studied in a control phase, 1 month of PC 2 mEq/kg/day, 2 months of PC 3 mEq/kg/day and 1 month of PC 4 mEq/kg/day. The urine specimens of 41 normal children were measured for the reference value of the parameters determining the risk of calcium stone. Results: Eight children (mean age of 10 ± 3.7 years, female: male = 6:2) with distal RTA were studied during the control phase and after receiving PC 2 mEq/kg/day for 1 month. Treatment with PC 2 mEq/kg/day was not able to normalize serum bicarbonate and caused no significant change in the urine citrate/creatinine ratio, and activity production of calcium phosphate stone but it caused a significant decrease in the urine calcium/citrate ratio. Although PC 3 mEq/kg/day for 1 month normalized plasma bicarbonate, only this dose given for 2 months caused a significant increase in the urine citrate/creatinine ratio and urine calcium/ citrate ratio to values that were not different from normal children, while the activity production of calcium phosphate stone did not decrease to normal level. The effect of PC 4 mEq/kg/day was similar to that of 3 mEq/kg/day. Conclusion: Potassium citrate 3 mEq/kg/day for 2 months effectively normalized serum bicarbonate and decreased the risk of calcium oxalate stone but this treatment was theoretically unable to reduce the risk of calcium phosphate stone in children with distal RTA.